Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $25.79M | $23.68M | $22.06M | $17.75M |
| Net Income | $8.95M | $8.38M | $6.17M | $4.96M |
| EPS Diluted | $0.59 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.55 |
| $0.40 |
| $0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
